This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and assessment of a behavioral economic intervention to improve HIV-related behaviors among sexual minority men (SMM). The $264,091 award, effective September 15, 2024, aims to refine and evaluate the feasibility and acceptability of an Episodic Future Thinking (EFT) intervention delivered via smartphone to address delayed...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will provide $181,974 over 5 years to The Johns Hopkins University to conduct implementation science research optimizing HIV prevention and harm reduction services for men who have sex with men engaged in transactional sex in Baltimore, Maryland. The award will fund training and mentored research for the principal investigator, Dr. Atkins, to...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,681,276 to the Research Foundation of the City University of New York (RFCUNY) to conduct research on optimizing long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) strategies for sexual minority men (SMM) who use methamphetamine. The study aims to qualitatively identify modifiable care options for LAI PrEP use through rapid interviews,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,481,760 to Emory University to study how methamphetamine (MA) use impacts immune dysfunction in people living with HIV (PWH) on antiretroviral therapy (ART). The 5-year award will leverage existing longitudinal blood samples and collect new blood and cerebrospinal fluid samples to investigate a multi-step process by which MA promotes...
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...
The National Institute on Drug Abuse (NIDA) awarded a $786,979 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of California, San Diego (UCSD) to implement a two-prong hybrid trial focused on improving identification and treatment of substance use disorder (SUD) among sexual and gender minorities of color (SGMC) in Chicago. The first prong involves implementing routine screening for SUD using the NIDA Quick Screen. The second prong is a social network...
This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,756,612 to the University of California, Los Angeles (UCLA) to conduct research on the impacts of racial inequality on substance use and HIV outcomes among sexual minority men of color in Los Angeles County. The key products and services to be delivered under this 5-year award include: 1) investigating how historical racist practices influence...
The federal Project Grant award, identified as R61DA062365, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,551,042 award will establish a Regional Research Hub (RRH) in the greater Metropolitan Atlanta area to improve linkages to care for a recently incarcerated, HIV status-neutral group of individuals experiencing substance use disorder (SUD). The project aims to: (1) pilot test a previously developed...
This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $405,490 to the University of Georgia Research Foundation, Inc. to characterize chemsex patterns and the adoption of harm reduction measures among men in the southern United States.
The key objectives of this 2-year project are to: (1) conduct in-depth interviews with 30 men to examine features of chemsex, such as drug use, sexual behaviors, psychosocial drivers, and harm reduction approaches; and (2) use ecological momentary assessment (EMA) to collect real-time data on drug use, sexual behavior, psychosocial variables, and harm reduction measures among 142 men who practice chemsex. This research aims to provide preliminary data on chemsex patterns, psychosocial drivers, and modifiable factors associated with chemsex, PrEP use, and condom use among men in Georgia, a southern state with a high HIV burden. The project will also evaluate the effectiveness of the EMA approach for tracking chemsex practices.